Prevalence and burden of HBV co‐infection among people living with HIV: a global systematic review and meta‐analysis

L Platt, CE French, CR McGowan, K Sabin… - Journal of viral …, 2020 - Wiley Online Library
Globally, in 2017 35 million people were living with HIV (PLHIV) and 257 million had chronic
HBV infection (HBsAg positive). The extent of HIV‐HBsAg co‐infection is unknown. We …

Increasing burden of liver disease in patients with HIV infection

D Joshi, J O'Grady, D Dieterich, B Gazzard, K Agarwal - The Lancet, 2011 - thelancet.com
Introduction of effective combined antiretroviral therapy has made HIV infection a chronic
illness. Substantial reductions in the number of AIDS-related deaths have been …

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration

CJ Smith, L Ryom, R Weber, P Morlat, C Pradier… - The Lancet, 2014 - thelancet.com
Background With the advent of effective antiretroviral treatment, the life expectancy for
people with HIV is now approaching that seen in the general population. Consequently, the …

ADAPT: an algorithm incorporating PRO‐C3 accurately identifies patients with NAFLD and advanced fibrosis

SJ Daniels, DJ Leeming, M Eslam, AM Hashem… - Hepatology, 2019 - journals.lww.com
The role of antiretroviral therapy (ART) in reducing or contributing to liver fibrosis in persons
with human immunodeficiency virus (HIV) is unclear. We evaluated participants in the …

Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C Virus–monoinfected patients: a cohort …

VL Re III, MJ Kallan, JP Tate, AR Localio… - Annals of internal …, 2014 - acpjournals.org
Background: The incidence and determinants of hepatic decompensation have been
incompletely examined among patients co-infected with HIV and hepatitis C virus (HCV) in …

Management of human immunodeficiency virus infection in advanced age

M Greene, AC Justice, HW Lampiris, V Valcour - Jama, 2013 - jamanetwork.com
Importance Human immunodeficiency virus (HIV)− positive patients treated with
antiretroviral therapy now have increased life expectancy and develop chronic illnesses that …

Alpha‐fetoprotein decrease from> 1,000 to< 500 ng/mL in patients with hepatocellular carcinoma leads to improved posttransplant outcomes

N Mehta, JL Dodge, JP Roberts, R Hirose, FY Yao - Hepatology, 2019 - journals.lww.com
Abstract High alpha‐fetoprotein (AFP)> 1,000 ng/mL is associated with poor outcomes after
liver transplantation (LT) for hepatocellular carcinoma (HCC). A new national policy has …

[HTML][HTML] Liver as a target of human immunodeficiency virus infection

M Ganesan, LY Poluektova… - World journal of …, 2018 - ncbi.nlm.nih.gov
Liver injury is a characteristic feature of human immunodeficiency virus (HIV) infection,
which is the second most common cause of mortality in HIV-infected patients. Now it is …

From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management

M Lemoine, L Serfaty, J Capeau - Current opinion in infectious …, 2012 - journals.lww.com
From nonalcoholic fatty liver to nonalcoholic steatohepatiti... : Current Opinion in Infectious
Diseases From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected …

Role of mitochondria in HIV infection and associated metabolic disorders: focus on nonalcoholic fatty liver disease and lipodystrophy syndrome

P Pérez-Matute, L Pérez-Martínez… - Oxidative medicine …, 2013 - Wiley Online Library
Highly active antiretroviral therapy (HAART) has considerably improved the prognosis of HIV‐
infected patients. However, prolonged use of HAART has been related to long‐term adverse …